The decision by an advisory committee may lead to Food and Drug Administration approval of the first treatment for humans that uses the CRISPR gene-editing system.
Author: GINA KOLATA
Advertisements
{
"slotId": "6845006044",
"unitType": "responsive",
"resize": "auto"
}